Breast-cancer screening-viewpoint of the IARC working group

New England Journal of Medicine

Volumn 372, Issue 24, 2015, Pages 2353-2358

  Lauby Secretan, Béatrice ^a   Scoccianti, Chiara ^a   Loomis, Dana ^a   Benbrahim Tallaa, Lamia ^a   Bouvard, Véronique ^a   Bianchini, Franca ^b   Straif, Kurt ^a   Armstrong, Bruce ^c   Anttila, Ahti ^c   De Koning, Harry J ^c   Smith, Robert A ^c   Thomas, David B ^c   Weiderpass, Elisabete ^c   Anderson, Benjamin O ^c   Badwe, Rajendra A ^c   Da Silva, Ronaldo Corrêa Ferreira ^c   De Bock, Geertruida H ^c   Duffy, Stephen W ^c   Ellis, Ian ^c   Hamashima, Chisato ^c   Houssami, Nehmat ^c   Kristensen, Vessela ^c   Miller, Anthony B ^c   Murillo, Raul ^c   Paci, Eugenio ^c   Patnick, Julietta ^c   Qiao, You Lin ^c   Rogel, Agnès ^c   Segnan, Nereo ^c   Shastri, Surendra S ^c   Solbjør, Marit ^c   Heywang Köbrunner, Sylvia H ^c   Yaffe, Martin J ^c   Forman, David ^c   Von Karsa, Lawrence ^c   Sankaranarayanan, Rengaswamy ^c   more..

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CANCER; BREAST EXAMINATION; CANCER MORTALITY; CANCER PREVENTION; CANCER RISK; CANCER SCREENING; CANCER STAGING; CLINICAL EFFECTIVENESS; CLINICAL EXAMINATION; CONSENSUS DEVELOPMENT; DIAGNOSTIC ERROR; EARLY DIAGNOSIS; EVIDENCE BASED MEDICINE; FALSE POSITIVE RESULT; GENE MUTATION; HIGH RISK POPULATION; HUMAN; INTENTION TO TREAT ANALYSIS; MAMMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RADIATION INDUCED NEOPLASM; RISK REDUCTION; SELF EXAMINATION; TREATMENT OUTCOME; TUMOR SUPPRESSOR GENE; ADULT; ADVISORY COMMITTEE; AGED; BREAST NEOPLASMS; BREAST SELF EXAMINATION; COST BENEFIT ANALYSIS; ECHOGRAPHY; FEMALE; GENETICS; MIDDLE AGED; MORTALITY; PRACTICE GUIDELINE; PROCEDURES; THREE DIMENSIONAL IMAGING;

ADULT; ADVISORY COMMITTEES; AGED; BREAST NEOPLASMS; BREAST SELF-EXAMINATION; COST-BENEFIT ANALYSIS; EARLY DETECTION OF CANCER; FEMALE; HUMANS; IMAGING, THREE-DIMENSIONAL; MAMMOGRAPHY; MIDDLE AGED; PRACTICE GUIDELINES AS TOPIC;

EID: 84930799154     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMsr1504363     Document Type: Article

References (40)

1. International Agency for Research on Cancer. IARC handbooks of cancer prevention. Vol. 7. Breast cancer screening. Lyon, France: IARC Press, 2002.
2. International Agency for Research on Cancer. Working procedures to the IARC handbooks of cancer prevention-screening. Lyon, France: IARC Press, 2014 (http://handbooks.iarc.fr/workingprocedures/index.php).
3. International Agency for Research on Cancer. IARC handbooks of cancer prevention. Vol. 15. Breast cancer screening. Lyon, France: IARC Press, 2015.
4. Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012. Vol 1.0. Estimated cancer incidence, mortality, and prevalence worldwide in 2012. Lyon, France: IARC Press, 2014 (http://globocan.iarc.fr/default.aspx).
5. Ferlay J, Bray F, Steliarova-Foucher E, Forman D. CI5 I-X: cancer incidence in five continents, volumes I to X. Lyon, France: IARC Press, 2014 (http://ci5.iarc.fr/cI5I-x/default.aspx).
6. Sankaranarayanan R, Swaminathan R, Brenner H, et al. Cancer survival in Africa, Asia, and Central America: a population-based study. Lancet Oncol 2010; 11: 165-73.
7. Colditz GA, Bohlke K. Priorities for the primary prevention of breast cancer. CA Cancer J Clin 2014; 64: 186-94.
8. von Karsa L, Dean P, Arrossi S, Sankaranarayanan R. Screening-principles. In: Stewart BW, Wild CP, eds. World cancer report. Lyon, France: IARC Press, 2014: 322-9.
9. UK Trial of Early Detection of Breast Cancer Group. 16-Year mortality from breast cancer in the UK Trial of Early Detection of Breast Cancer. Lancet 1999; 353: 1909-14.
10. Ascunce EN, Moreno-Iribas C, Barcos Urtiaga A, et al. Changes in breast cancer mortality in Navarre (Spain) after introduction of a screening programme. J Med Screen 2007; 14: 14-20.
11. Weedon-Fekj? H, Romundstad PR, Vatten LJ. Modern mammography screening and breast cancer mortality: population study. BMJ 2014; 348: g3701.
12. Olsen AH, Lynge E, Njor SH, et al. Breast cancer mortality in Norway after the introduction of mammography screening. Int J Cancer 2013; 132: 208-14.
13. Kalager M, Zelen M, Langmark F, Adami HO. Effect of screening mammography on breast-cancer mortality in Norway. N Engl J Med 2010; 363: 1203-10.
14. Morrison AS, Brisson J, Khalid N. Breast cancer incidence and mortality in the Breast Cancer Detection Demonstration Project. J Natl Cancer Inst 1988; 80: 1540-7. [Erratum, J Natl Cancer Inst 1989;81:1513.].
15. Thompson RS, Barlow WE, Taplin SH, et al. A populationbased case-cohort evaluation of the efficacy of mammographic screening for breast cancer. Am J Epidemiol 1994; 140: 889-901.
16. Hofvind S, Ursin G, Tretli S, Sebu?eg?d S, M?ler B. Breast cancer mortality in participants of the Norwegian Breast Cancer Screening Program. Cancer 2013; 119: 3106-12.
17. Coldman A, Phillips N, Wilson C, et al. Pan-Canadian study of mammography screening and mortality from breast cancer. J Natl Cancer Inst 2014; 106: dju261.
18. van Dijck JA, Broeders MJ, Verbeek AL. Mammographic screening in older women. is it worthwhile? Drugs Aging 1997; 10: 69-79.
19. Jonsson H, T?nberg S, Nystr? L, Lenner P. Service screening with mammography of women aged 70-74 years in Sweden: effects on breast cancer mortality. Cancer Detect Prev 2003; 27: 360-9.
20. Elmore JG, Reisch LM, Barton MB, et al. Efficacy of breast cancer screening in the community according to risk level. J Natl Cancer Inst 2005; 97: 1035-43.
21. Norman SA, Russell Localio A, Weber AL, et al. Protection of mammography screening against death from breast cancer in women aged 40-64 years. Cancer Causes Control 2007; 18: 909-18.
22. Roder D, Houssami N, Farshid G, et al. Population screening and intensity of screening are associated with reduced breast cancer mortality: evidence of efficacy of mammography screening in Australia. Breast Cancer Res Treat 2008; 108: 409-16.
23. van Schoor G, Moss SM, Otten JD, et al. Effective biennial mammographic screening in women aged 40-49. Eur J Cancer 2010; 46: 3137-40.
24. Hofvind S, Ponti A, Patnick J, et al. False-positive results in mammographic screening for breast cancer in Europe: a literature review and survey of service screening programmes. J Med Screen 2012; 19: Suppl 1: 57-66.
25. Hubbard RA, Kerlikowske K, Flowers CI, Yankaskas BC, Zhu W, Miglioretti DL. Cumulative probability of false-positive recall or biopsy recommendation after 10 years of screening mammography: a cohort study. Ann Intern Med 2011; 155: 481-92.
26. Bond M, Pavey T, Welch K, et al. Systematic review of the psychological consequences of false-positive screening mammograms. Health Technol Assess 2013; 17: 1-170.
27. Puliti D, Duffy SW, Miccinesi G, et al. Overdiagnosis in mammographic screening for breast cancer in Europe: a literature review. J Med Screen 2012; 19: Suppl 1: 42-56.
28. Paci E. Summary of the evidence of breast cancer service screening outcomes in Europe and first estimate of the benefit and harm balance sheet. J Med Screen 2012; 19: Suppl 1: 5-13.
29. Zackrisson S, Andersson I, Janzon L, Manjer J, Garne JP. Rate of over-diagnosis of breast cancer 15 years after end of Malm?mammographic screening trial: follow-up study. BMJ 2006; 332: 689-92.
30. Miller AB, Wall C, Baines CJ, Sun P, To T, Narod SA. Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial. BMJ 2014; 348: g366.
31. Advisory Group on Ionising Radiation. Risk of solid cancers following radiation exposure: estimates for the UK population. London: Health Protection Agency, 2011 (https://www.gov.uk/government/uploads/system/uploads/attachment-data/file/334311/RCE-19-for-website-v2.pdf).
32. Houssami N, Ciatto S. The evolving role of new imaging methods in breast screening. Prev Med 2011; 53: 123-6.
33. Ciatto S, Houssami N, Bernardi D, et al. Integration of 3D digital mammography with tomosynthesis for population breastcancer screening (STORM): a prospective comparison study. Lancet Oncol 2013; 14: 583-9.
34. Mittra I, Mishra GA, Singh S, et al. A cluster randomized, controlled trial of breast and cervix cancer screening in Mumbai, India: methodology and interim results after three rounds of screening. Int J Cancer 2010; 126: 976-84.
35. Sankaranarayanan R, Ramadas K, Thara S, et al. Clinical breast examination: preliminary results from a cluster randomized controlled trial in India. J Natl Cancer Inst 2011; 103: 1476-80.
36. Pisani P, Parkin DM, Ngelangel C, et al. Outcome of screening by clinical examination of the breast in a trial in the Philippines. Int J Cancer 2006; 118: 149-54.
37. Jansen-van der Weide MC, Greuter MJ, Jansen L, Oosterwijk JC, Pijnappel RM, de Bock GH. Exposure to low-dose radiation and the risk of breast cancer among women with a familial or genetic predisposition: a meta-analysis. Eur Radiol 2010; 20: 2547-56.
38. Phi X-A, Houssami N, Obdeijn IM, et al. Magnetic resonance imaging improves breast screening sensitivity in BRCA mutation carriers age = 50 years: evidence from an individual patient data meta-analysis. J Clin Oncol 2015; 33: 349-56.
39. Warner E, Messersmith H, Causer P, Eisen A, Shumak R, Plewes D. Systematic review: using magnetic resonance imaging to screen women at high risk for breast cancer. Ann Intern Med 2008; 148: 671-9.
40. Lord SJ, Lei W, Craft P, et al. A systematic review of the effectiveness of magnetic resonance imaging (MRI) as an addition to mammography and ultrasound in screening young women at high risk of breast cancer. Eur J Cancer 2007; 43: 1905-17.